BioScience Health Innovations annual shareholders’ equity
2020
2021
2022
2022
2023
2024
2025
BioScience Health Innovations Shareholders’ Equity Growth & History (BHIC)
BioScience Health Innovations's shareholders’ equity was $1.5M for fiscal 2025.
View full BioScience Health Innovations company overviewBioScience Health Innovations annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.5M | $642,090 | +76.87% |
| 2024 | 2024-12-31 | $835,240 | $842,000 | — |
| 2023 | 2023-12-31 | −$6,760 | $10,423 | — |
| 2022 · Dec 31 | 2022-12-31 | −$17,183 | — | — |
| 2022 · Aug 31 | 2022-08-31 | $14,393 | $27,185 | — |
| 2021 | 2021-08-31 | −$12,792 | −$25,610 | — |
| 2020 | 2020-08-31 | $12,818 | — | — |
BioScience Health Innovations quarterly shareholders’ equity
As of Aug 31, 2019
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q4.22
Q1.23
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.8M | $115,199 | +6.70% |
| Q1 2026 | 2026-03-31 | $1.7M | $422,452 | +33.47% |
| Q4 2025 | 2025-12-31 | $1.5M | $642,090 | +76.87% |
| Q3 2025 | 2025-09-30 | $1.7M | $1.3M | +362.07% |
| Q2 2025 | 2025-06-30 | $1.7M | $1.5M | +809.53% |
| Q1 2025 | 2025-03-31 | $1.3M | $1.1M | +998.77% |
| Q4 2024 | 2024-12-31 | $835,240 | $842,000 | — |
| Q3 2024 | 2024-09-30 | $370,283 | $361,681 | +4204.62% |
| Q2 2024 | 2024-06-30 | $189,081 | $243,333 | — |
| Q1 2024 | 2024-03-31 | $114,859 | $203,849 | — |
| Q4 2023 | 2023-12-31 | −$6,760 | $10,423 | — |
| Q3 2023 | 2023-09-30 | $8,602 | — | — |
| Q2 2023 | 2023-06-30 | −$54,252 | — | — |
| Q1 2023 · Mar 31 | 2023-03-31 | −$88,990 | — | — |
| Q1 2023 · Feb 28 | 2023-02-28 | $5,491 | −$50,101 | −90.12% |
| Q4 2022 · Dec 31 | 2022-12-31 | −$17,183 | — | — |
| Q1 2023 · Nov 30 | 2022-11-30 | $25,476 | −$47,643 | −65.16% |
| Q4 2022 · Aug 31 | 2022-08-31 | $14,393 | $27,185 | — |
| Q3 2022 | 2022-05-31 | $7,708 | $16,345 | — |
| Q2 2022 | 2022-02-28 | $55,592 | $61,020 | — |
| Q1 2022 | 2021-11-30 | $73,119 | $65,879 | +909.93% |
| Q4 2021 | 2021-08-31 | −$12,792 | −$25,610 | — |
| Q3 2021 | 2021-05-31 | −$8,637 | $7,076 | — |
| Q2 2021 | 2021-02-28 | −$5,428 | −$5,402 | — |
| Q1 2021 | 2020-11-30 | $7,240 | $5,340 | +281.05% |
| Q4 2020 | 2020-08-31 | $12,818 | $10,918 | +574.63% |
| Q3 2020 | 2020-05-31 | −$15,713 | — | — |
| Q2 2020 | 2020-02-29 | −$26 | — | — |
| Q1 2020 | 2019-11-30 | $1,900 | — | — |
| As of Aug 31, 2019 | 2019-08-31 | $1,900 | — | — |
BioScience Health Innovations shareholders’ equity trends
Between the periods ended 2020-08-31 and 2025-12-31, BioScience Health Innovations's shareholders’ equity increased from $12,818 to $1.5M, a change of $1.5M. The latest reported quarter, Q2 2026, shows $1.8M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioScience Health Innovations source filings ↗